South Africa caps tirzepatide prescribing to 17 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
Insurance
Page 6 of 10 of this archive, newest first.
Japan declines to reimburse tirzepatide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
Mexico caps semaglutide prescribing to 21 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
Australia caps liraglutide prescribing to 10 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
Argentina declines to reimburse exenatide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
Australia caps tirzepatide prescribing to 17 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
South Africa caps tirzepatide prescribing to 17 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
Singapore declines to reimburse dulaglutide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
Ireland caps exenatide prescribing to 19 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
Ireland caps tirzepatide prescribing to 17 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
The United Arab Emirates caps exenatide prescribing to 19 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
Saudi Arabia caps dulaglutide prescribing to 9 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
South Korea declines to reimburse tirzepatide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
Switzerland caps semaglutide prescribing to 8 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
Japan declines to reimburse exenatide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
Turkey caps liraglutide prescribing to 12 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
India caps liraglutide prescribing to 17 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
Sweden caps tirzepatide prescribing to 16 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
India declines to reimburse dulaglutide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
Nigeria caps tirzepatide prescribing to 6 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.